+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
MEDICAMEQ

Medicamen Biotech Share Price

₹279.55 -1.4 (-0.5%)
37.55% Fall from 52W High

09 Nov, 2026 3:51 PM (IST)

Medicamen Biotech live price: ₹279.55. It opened at ₹284 vs previous close ₹281; intraday high/low: ₹287/₹276. The 50 & 200 DMA stand at ₹278.00/₹288.40.

Medicamen Biotech Performance

  • Today's Low
  • ₹276
  • Today's High
  • ₹287
  • 52 Week Low
  • ₹212
  • 52 Week High
  • ₹448
  • Open Price₹284
  • Previous Close₹281
  • Volume3,608
  • 50 DMA₹278.00
  • 100 DMA₹275.60
  • 200 DMA₹288.40

Medicamen Biotech Chart

Investment Returns

  • Over 1 Month -7.08%
  • Over 3 Month + 18.61%
  • Over 6 Month -5.01%
  • Over 1 Year -31.1%

Smart Investing Starts Here Start SIP with Medicamen Biotech for Steady Growth!

Invest Now

Medicamen Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 36.3
  • PEG Ratio
  • 1.7
  • Market Cap Cr
  • 393
  • P/B Ratio
  • 1.4
  • Average True Range
  • 14.7
  • EPS
  • 7.7
  • Dividend Yield
  • 0.4
  • MACD Signal
  • -5.3
  • RSI
  • 51.77
  • MFI
  • 53.2

Latest Stock News Updates

Medicamen Biotech Ltd-$ - 531146 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Regulation 74 (5) of SEBI (DP) Regulation 2018- September 30, 2026

Medicamen Biotech Ltd-$ - 531146 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shivalik Rasayan Ltd & Growel Remedies Ltd

Medicamen Biotech Ltd-$ - 531146 - Announcement under Regulation 30 (LODR)-Allotment

Outcome of the meeting of Preferential Issue Commitee of the Board of Directors of Medicamen Biotech Limited to consider and approve the allotmentb of 5,00,000 Equity Shares pursuant to conversion of 5,00,000 fully convertible warrants at an issue price of Rs. 530/- per Equity Share

Medicamen Biotech Financials

Medicamen Biotech Technicals

EMA & SMA

Current Price
₹279.55
-1.4 (-0.5%)
pointer
  • Bearish Moving Average 3
  • Bullish Moving Average 13
  • 20 Day
  • ₹274.40
  • 50 Day
  • ₹278.00
  • 100 Day
  • ₹275.60
  • 200 Day
  • ₹288.40

Resistance and Support

280.72 Pivot Speed
  • R3 297.10
  • R2 292.00
  • R1 285.80
  • S1 274.50
  • S2 269.40
  • S3 263.20

Medicamen Biotech Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-11-13 Quarterly Results
2026-08-14 Quarterly Results
2026-05-27 Final Dividend
2026-02-13 Quarterly Results
2025-11-14 Quarterly Results
Date Purpose Remarks
2026-09-19 FINAL Rs.1.00 per share(10%)Final Dividend
2025-09-19 FINAL Rs.1.00 per share(10%)Final Dividend (RD & XD dates revised)
View Medicamen Biotech Dividend History Arrow

Medicamen Biotech Shareholding Pattern

55%
40.46%
4.49%
0.05%

About Medicamen Biotech

Medicamen Biotech engaged in the research, development and manufacturing, and global marketing of Finished Dosage Forms (FDFs) and liquid formulations. MBL specializes in Oncology, Cardiovascular Diseases (CVD), Central Nervous System (CNS), Diabetology, Anti-Malarials, Antibiotics and Pain Managemen with an established presence across more than 35 countries in the Rest of the World (ROW) and an expanding footprint in highly regulated markets, View More
  • NSE Symbol
  • MEDICAMEQ
  • BSE Symbol
  • 531146
  • ISIN
  • INE646B01010

Similar Stocks to Medicamen Biotech

Medicamen Biotech FAQs

Medicamen Biotech share price is ₹279 As on 10 November, 2026 | 20:36

The Market Cap of Medicamen Biotech is ₹393.1 Cr As on 10 November, 2026 | 20:36

The P/E ratio of Medicamen Biotech is 36.3 As on 10 November, 2026 | 20:36

The PB ratio of Medicamen Biotech is 1.4 As on 10 November, 2026 | 20:36

The 52 week High & Low of Medicamen Biotech is ₹447.6/₹212.4 respectively As on 10 November, 2026 | 20:36

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23